HFS
FULC icon

Hughes Financial Services’s Fulcrum Therapeutics FULC Stock Holding History

Hughes Financial Services’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$8 – 1885
2026
Q1 		$8 Buy
+1
New +$9 ﹤0.01% 1698

Other funds holding FULC

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Hughes Financial Services's FULC Position: Q2 2026 in Review

Hughes Financial Services sold out of Fulcrum Therapeutics (FULC) in Q2 2026, closing a stake of 1 share — an estimated $8 sold.

Hughes Financial Services first reported a position in FULC in Q1 2026 and held it in 1 quarter. The position peaked at $8 in Q1 2026. 12 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Hughes Financial Services reported no remaining Fulcrum Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Hughes Financial Services sold 1 Fulcrum Therapeutics share in Q2 2026, an estimated $8.
  • Hughes Financial Services first reported a position in Fulcrum Therapeutics in Q1 2026 and held it in 1 quarter.
  • Hughes Financial Services's Fulcrum Therapeutics position peaked at $8 in Q1 2026.
  • 12 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.